NCT05467397 2026-01-21
Feasibility of [11C]Acetate-PET in LAM and TSC
Brigham and Women's Hospital
Phase 1/2 Active not recruiting
Clinical Trials
10 trialsNCT02715583 2022-05-18
C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT00813566 2022-04-27
Multi-Tracer PET Assessment of Primary Brain Tumors
University of Utah
Phase 1 Completed
NCT02826395 2020-07-24
C11 Sodium Acetate PET/CT Imaging of PCa
Jonsson Comprehensive Cancer Center
No longer available
NCT01304485 2019-03-07
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma
Phoenix Molecular Imaging
Phase 2 Completed
NCT01144897 2018-10-02
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
University of Iowa
Phase 1 Completed
NCT01777061 2018-05-16
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
University of Kansas Medical Center
No longer available
NCT02549755 2017-11-22
11C-acetate for Treatment Response After Radiotherapy for HCC
Indiana University
Phase 2 Terminated
NCT01961934 2016-09-28
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
Phoenix Molecular Imaging
Phase 2/3 Withdrawn
NCT02169063 2016-08-31
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer
University of Washington
Phase NA Withdrawn